2020 ACR指南:风湿性和肌肉骨骼疾病生殖健康的管理

2020-02-23 美国风湿病学会 Arthritis Rheumatol. 2020 Feb 23.

2020年2月,美国风湿病学会(ACR)发布了风湿性和肌肉骨骼疾病生殖健康的管理指南,本文主要针对风湿性和肌肉骨骼疾病(RMD)患者的避孕、辅助生殖技术、更年期激素替代疗法、妊娠风险评估和管理等内容提供循证指导建议。

中文标题:

2020 ACR指南:风湿性和肌肉骨骼疾病生殖健康的管理

英文标题:

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

发布机构:

美国风湿病学会

发布日期:

2020-02-23

简要介绍:

2020年2月,美国风湿病学会(ACR)发布了风湿性和肌肉骨骼疾病生殖健康的管理指南,本文主要针对风湿性和肌肉骨骼疾病(RMD)患者的避孕、辅助生殖技术、更年期激素替代疗法、妊娠风险评估和管理等内容提供循证指导建议。

 

拓展指南:风湿相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2020 ACR指南:风湿性和肌肉骨骼疾病生殖健康的管理)] GetToolGuiderByIdResponse(projectId=1, id=2b4c81c0018e15f4, title=2020 ACR指南:风湿性和肌肉骨骼疾病生殖健康的管理, enTitle=2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases., guiderFrom=Arthritis Rheumatol. 2020 Feb 23., authorId=null, author=, summary=2020年2月,美国风湿病学会(ACR)发布了风湿性和肌肉骨骼疾病生殖健康的管理指南,本文主要针对风湿性和肌肉骨骼疾病(RMD)患者的避孕、辅助生殖技术、更年期激素替代疗法、妊娠风险评估和管理等内容提供循证指导建议。 , cover=, journalId=null, articlesId=null, associationId=528, associationName=美国风湿病学会, associationIntro=The American College of Rheumatology&#039;s mission is advancing rheumatology. The organization is for physicians, health professionals, and scientists that meets the mission through programs of education, research, advocacy and practice support. The ACR provides professional education for its members through several venues. The Annual Scientific Meeting, held each fall, is the premier scientific meeting devoted to the rheumatic diseases. This meeting draws thousands of rheumatologists and arthritis health professionals from around the world. A winter rheumatology symposium, spring clinical meetings, and other topical conferences round out the ACR&#039;s educational offerings., copyright=0, guiderPublishedTime=Sun Feb 23 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年2月,美国风湿病学会(ACR)发布了风湿性和肌肉骨骼疾病生殖健康的管理指南,本文主要针对风湿性和肌肉骨骼疾病(RMD)患者的避孕、辅助生殖技术、更年期激素替代疗法、妊娠风险评估和管理等内容提供循证指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>风湿</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=2dc361c0018e09b3" title="2020 香港共识声明:生物类改善病情的抗风湿药(DMARDs)治疗多关节型JIA、附着点炎相关关节炎和银屑病关节炎" target=_blank>2020 香港共识声明:生物类改善病情的抗风湿药(DMARDs)治疗多关节型JIA、附着点炎相关关节炎和银屑病关节炎</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=142071c001860069" title="2019 EULAR建议:应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎" target=_blank>2019 EULAR建议:应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=98ad71c001829146" title="锝[99Tc]亚甲基二膦酸盐注射液治疗类风湿关节炎专家共识" target=_blank>锝[99Tc]亚甲基二膦酸盐注射液治疗类风湿关节炎专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=e0ecc1c0018132c8" title="中药新药用于类风湿关节炎临床研究技术指导原则" target=_blank>中药新药用于类风湿关节炎临床研究技术指导原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=7adab1c00180117d" title="2019 NICE诊断指南:类风湿性关节炎TNF-α抑制剂治疗监测(DG.36)" target=_blank>2019 NICE诊断指南:类风湿性关节炎TNF-α抑制剂治疗监测(DG.36)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E9%A3%8E%E6%B9%BF" target=_blank>有关风湿更多指南</a></ul>, tagList=[TagDto(tagId=22035, tagName=风湿性疾病), TagDto(tagId=67237, tagName=肌肉骨骼疾病), TagDto(tagId=34099, tagName=生殖健康)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7861, appHits=165, showAppHits=9, pcHits=3611, showPcHits=5595, likes=11, shares=12, comments=2, approvalStatus=1, publishedTime=Sat Feb 29 23:19:53 CST 2020, publishedTimeString=2020-02-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Feb 29 23:19:53 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 12:12:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 ACR指南:风湿性和肌肉骨骼疾病生殖健康的管理)])
2020 ACR指南:风湿性和肌肉骨骼疾病生殖健康的管理
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=920010, encodeId=0173920010d2, content=很不错 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3465440360, createdName=ms2000001305238612, createdTime=Tue Jan 26 15:41:44 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897985, encodeId=56b189e98553, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e85433204, createdName=Sarah2020cpp, createdTime=Mon Nov 09 15:33:00 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
    2021-01-26 ms2000001305238612

    很不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=920010, encodeId=0173920010d2, content=很不错 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3465440360, createdName=ms2000001305238612, createdTime=Tue Jan 26 15:41:44 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897985, encodeId=56b189e98553, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e85433204, createdName=Sarah2020cpp, createdTime=Mon Nov 09 15:33:00 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
    2020-11-09 Sarah2020cpp

    很不错

    0